Various novel treatments addressing the pathogenic mechanisms of HIV-induced brain disease are currently under investigation, including PPAR-gamma agonists, PD1 inhibition, curcumin, intranasal insulin, and Jak inhibitors. The gene discussed is INS; the disease is brain disorder.